Nanotechnology as a therapeutic tool to combat microbial resistance.

Use of nanoparticles is among the most promising strategies to overcome microbial drug resistance. This review article consists of three parts. The first part discusses the epidemiology of microbial drug resistance. The second part describes mechanisms of drug resistance used by microbes. The third part explains how nanoparticles can overcome this resistance, including the following: Nitric oxide-releasing nanoparticles (NO NPs), chitosan-containing nanoparticles (chitosan NPs), and metal-containing nanoparticles all use multiple mechanisms simultaneously to combat microbes, thereby making development of resistance to these nanoparticles unlikely. Packaging multiple antimicrobial agents within the same nanoparticle also makes development of resistance unlikely. Nanoparticles can overcome existing drug resistance mechanisms, including decreased uptake and increased efflux of drug from the microbial cell, biofilm formation, and intracellular bacteria. Finally, nanoparticles can target antimicrobial agents to the site of infection, so that higher doses of drug are given at the infected site, thereby overcoming resistance.

[1]  Advances in industrial biofilm control with micro-nanotechnology , 2011 .

[2]  E. Stobberingh,et al.  The molecular evolution of hospital- and community-associated methicillin-resistant Staphylococcus aureus. , 2009, Current molecular medicine.

[3]  A. Friedman,et al.  The growing role of nanotechnology in combating infectious disease , 2011, Virulence.

[4]  Young Jik Kwon,et al.  "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[5]  P. Courvalin,et al.  VanA-Type Vancomycin-Resistant Staphylococcus aureus , 2009, Antimicrobial Agents and Chemotherapy.

[6]  T. Triglia,et al.  Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  G. W. Young,et al.  In vitro antimicrobial studies of silver carbene complexes: activity of free and nanoparticle carbene formulations against clinical isolates of pathogenic bacteria. , 2012, The Journal of antimicrobial chemotherapy.

[8]  J. Friedman,et al.  Nitric oxide releasing nanoparticle synthesis and characterization. , 2011, Methods in molecular biology.

[9]  K. Poole Mechanisms of bacterial biocide and antibiotic resistance. , 2002, Symposium series.

[10]  J. Friedman,et al.  Nitric Oxide Releasing Nanoparticles Are Therapeutic for Staphylococcus aureus Abscesses in a Murine Model of Infection , 2009, PloS one.

[11]  M. Vayssier-Taussat,et al.  Transmission of Bartonella henselae by Ixodes ricinus , 2008, Emerging infectious diseases.

[12]  M. Vieira,et al.  A review of current and emergent biofilm control strategies , 2010 .

[13]  K. Arévalo-Niño,et al.  Zerovalent bismuth nanoparticles inhibit Streptococcus mutans growth and formation of biofilm , 2012, International journal of nanomedicine.

[14]  J. Davies,et al.  Origins and Evolution of Antibiotic Resistance , 1996, Microbiology and Molecular Biology Reviews.

[15]  R. Proctor Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  H. Chambers,et al.  Penicillin-binding protein-mediated resistance in pneumococci and staphylococci. , 1999, The Journal of infectious diseases.

[17]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[18]  Liyuan Ma,et al.  Targeted nanoparticles for enhanced X-ray radiation killing of multidrug-resistant bacteria. , 2013, Nanoscale.

[19]  Adam J. Friedman,et al.  The potential of nitric oxide releasing therapies as antimicrobial agents , 2012, Virulence.

[20]  P. Gao,et al.  Recent advances in materials for extended-release antibiotic delivery system , 2011, The Journal of Antibiotics.

[21]  Adam J Friedman,et al.  Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection. , 2009, The Journal of investigative dermatology.

[22]  A. Friedman,et al.  Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a targeted therapy for cutaneous pathogens , 2012, The Journal of investigative dermatology.

[23]  A. Robicsek,et al.  Prevalence in the United States of aac(6′)-Ib-cr Encoding a Ciprofloxacin-Modifying Enzyme , 2006, Antimicrobial Agents and Chemotherapy.

[24]  L. R. Martinez Nitric oxide-releasing nanoparticles: challenges and future prospects. , 2012, Therapeutic delivery.

[25]  Buchang Zhang,et al.  Nanoalumina promotes the horizontal transfer of multiresistance genes mediated by plasmids across genera , 2012, Proceedings of the National Academy of Sciences.

[26]  N. Woodford,et al.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study , 2010, The Lancet. Infectious diseases.

[27]  L. Martínez-Martínez,et al.  Mutational analysis of quinolone resistance in the plasmid-encoded pentapeptide repeat proteins QnrA, QnrB and QnrS. , 2009, The Journal of antimicrobial chemotherapy.

[28]  Sherine O. Obare,et al.  Nanoparticles Functionalized with Ampicillin Destroy Multiple-Antibiotic-Resistant Isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and Methicillin-Resistant Staphylococcus aureus , 2012, Applied and Environmental Microbiology.

[29]  J. Friedman,et al.  The use of nitric oxide releasing nanoparticles as a treatment against Acinetobacter baumannii in wound infections , 2010, Virulence.

[30]  M. Schoenfisch,et al.  Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. , 2009, Biomaterials.

[31]  B. Gibbins,et al.  Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. , 2008, The Journal of antimicrobial chemotherapy.

[32]  Leo H. Koole,et al.  New Strategies in the Development of Antimicrobial Coatings: The Example of Increasing Usage of Silver and Silver Nanoparticles , 2011 .

[33]  A. Ditto,et al.  The antimicrobial efficacy of sustained release silver-carbene complex-loaded L-tyrosine polyphosphate nanoparticles: characterization, in vitro and in vivo studies. , 2009, Biomaterials.

[34]  R. Quintiliani Using pharmacodynamic and pharmacokinetic concepts to optimize treatment of infectious diseases , 2004 .

[35]  S. Levy,et al.  Antibacterial resistance worldwide: causes, challenges and responses , 2004, Nature Medicine.

[36]  J. Friedman,et al.  Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione. , 2011, Nitric oxide : biology and chemistry.

[37]  Chun-Ming Huang,et al.  Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids. , 2011, Biomaterials.

[38]  Ian G. Macreadie,et al.  Dihydropteroate Synthase Mutations in Pneumocystis jiroveci Can Affect Sulfamethoxazole Resistance in a Saccharomyces cerevisiae Model , 2004, Antimicrobial Agents and Chemotherapy.

[39]  A. Ficai,et al.  Magnetite nanoparticles for functionalized textile dressing to prevent fungal biofilms development , 2012, Nanoscale Research Letters.

[40]  L. H. Hansen,et al.  The macrolide–ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA , 1999, Molecular microbiology.

[41]  Chun-Ming Huang,et al.  Development of nanoparticles for antimicrobial drug delivery. , 2010, Current medicinal chemistry.

[42]  J. Friedman,et al.  Susceptibility of Gram-positive and -negative bacteria to novel nitric oxide-releasing nanoparticle technology , 2011, Virulence.

[43]  J. Friedman,et al.  Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites. , 2008, Nitric oxide : biology and chemistry.

[44]  A. Alanis,et al.  Resistance to antibiotics: are we in the post-antibiotic era? , 2005, Archives of medical research.

[45]  B. Ratner,et al.  Bioinspired implant materials befuddle bacteria , 2004 .

[46]  Michael R Hamblin,et al.  Synergistic Combination of Chitosan Acetate with Nanoparticle Silver as a Topical Antimicrobial: Efficacy against Bacterial Burn Infections , 2011, Antimicrobial Agents and Chemotherapy.

[47]  G. Jacoby,et al.  Updated Functional Classification of β-Lactamases , 2009, Antimicrobial Agents and Chemotherapy.

[48]  P. Higgins,et al.  Fluoroquinolones: structure and target sites. , 2003, Current drug targets.

[49]  A. Robicsek,et al.  Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase , 2006, Nature Medicine.

[50]  Morteza Mahmoudi,et al.  Antibacterial properties of nanoparticles. , 2012, Trends in biotechnology.

[51]  A. Grumezescu,et al.  Hybrid magnetite nanoparticles/Rosmarinus officinalis essential oil nanobiosystem with antibiofilm activity , 2012, Nanoscale Research Letters.

[52]  S. M. Robinson,et al.  Resistance is futile: the bacteriocin model for addressing the antibiotic resistance challenge. , 2012, Biochemical Society transactions.

[53]  Susan E. Brown,et al.  Isothermal Amplification and Molecular Typing of the Obligate Intracellular Pathogen Mycobacterium leprae Isolated from Tissues of Unknown Origins , 2006, Journal of Clinical Microbiology.

[54]  Malcolm N. Jones,et al.  The Delivery of Benzyl Penicillin to Staphylococcus aureus Biofilms by Use of Liposomes , 2004, Journal of liposome research.

[55]  M. Schoenfisch,et al.  Examination of bacterial resistance to exogenous nitric oxide. , 2012, Nitric oxide : biology and chemistry.

[56]  A. Gedanken,et al.  Antibiofilm surface functionalization of catheters by magnesium fluoride nanoparticles , 2012, International journal of nanomedicine.

[57]  Cristina Rodríguez Padilla,et al.  Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria , 2010 .

[58]  R. Jayaraman,et al.  Antibiotic resistance: an overview of mechanisms and a paradigm shift , 2009 .

[59]  J. Friedman,et al.  Nitric oxide nanoparticles , 2012, Virulence.

[60]  T. Hackstadt,et al.  The diverse habitats of obligate intracellular parasites. , 1998, Current opinion in microbiology.

[61]  Nikokar Iraj,et al.  Effects of Salt Stress on the Antimicrobial Drug Resistance and Protein Profile of Staphylococcus aureus , 2012 .

[62]  R. Humphries,et al.  The emerging problem of linezolid-resistant Staphylococcus. , 2013, The Journal of antimicrobial chemotherapy.